BioLineRx Ltd.: Form 20-F for the period ended Dec 31, 2025
Filed with the SEC on Mar 23, 2026 and accepted by EDGAR at Mar 23, 2026, 11:09 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $1.2m | ifrs-full:Revenue |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $230.0k | ifrs-full:CostOfSales |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | $950.0k | ifrs-full:GrossProfit |
| Operating income | 12 months2025-01-01 to 2025-12-31 | −$10.3m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2025-01-01 to 2025-12-31 | $0 | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2025-01-01 to 2025-12-31 | −$2.0m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | $0.00 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | $0.00 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | −$8.1m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $25.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2025-12-31 | $3.3m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2025-12-31 | $23.7m | ifrs-full:CurrentAssets |
| Total assets | At period end2025-12-31 | $40.9m | ifrs-full:Assets |
| Current liabilities | At period end2025-12-31 | $12.1m | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2025-12-31 | $17.6m | ifrs-full:Liabilities |
| Shareholders' equity | At period end2025-12-31 | $18.2m | ifrs-full:EquityAttributableToOwnersOfParent |
Source: SEC EDGAR, the filing index for accession 0001178913-26-001581. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.